CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 92 filers reported holding CONCERT PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $15,000 | -21.1% | 4,501 | +0.6% | 0.00% | – |
| Q2 2021 | $19,000 | -9.5% | 4,472 | +8.5% | 0.00% | – |
| Q1 2021 | $21,000 | +23.5% | 4,123 | +191.4% | 0.00% | – |
| Q1 2019 | $17,000 | -43.3% | 1,415 | -41.5% | 0.00% | – |
| Q4 2018 | $30,000 | -16.7% | 2,419 | 0.0% | 0.00% | – |
| Q3 2018 | $36,000 | -12.2% | 2,419 | 0.0% | 0.00% | – |
| Q2 2018 | $41,000 | -25.5% | 2,419 | 0.0% | 0.00% | – |
| Q1 2018 | $55,000 | -62.6% | 2,419 | -57.3% | 0.00% | -100.0% |
| Q4 2017 | $147,000 | +110.0% | 5,668 | +19.9% | 0.00% | 0.0% |
| Q3 2017 | $70,000 | +6.1% | 4,728 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $66,000 | -18.5% | 4,728 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $81,000 | +65.3% | 4,728 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $49,000 | – | 4,728 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| L1 Capital Pty Ltd | 1,050,124 | $10,312,000 | 3.31% |
| Alambic Investment Management, L.P. | 19,934 | $196,000 | 2.15% |
| INGALLS & SNYDER LLC | 1,363,603 | $13,391,000 | 0.92% |
| ACUTA CAPITAL PARTNERS, LLC | 300,000 | $2,946,000 | 0.80% |
| RA Capital Management | 1,858,474 | $18,250,000 | 0.33% |
| Perceptive Advisors | 2,150,641 | $21,119,000 | 0.31% |
| SPHERA FUNDS MANAGEMENT LTD. | 310,000 | $3,044,000 | 0.30% |
| Eversept Partners, LP | 103,829 | $1,019,601 | 0.23% |
| Opaleye Management Inc. | 100,000 | $982,000 | 0.19% |
| GSA CAPITAL PARTNERS LLP | 58,095 | $570,000 | 0.10% |